Related Experiment Video
Updated: May 23, 2025

07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
5.9K
Opioidergic modulation of monetary incentive delay fMRI responses
Samuel Turton1,2, Peter C T Hawkins3, Christopher Muller-Pollard4
1Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. samuel.turton@kcl.ac.uk.
Psychopharmacology
|March 7, 2025
Summary
Fentanyl increased brain activity in areas preparing for responses to visual cues, not in the striatum, during a reward anticipation task. This suggests opioids may not directly impact striatal reward processing.
Area of Science:
- Neuroscience
- Pharmacology
- Neuroimaging
Background:
- Opioid reward effects are hypothesized to involve striatal dopaminergic signaling.
- The Monetary Incentive Delay (MID) task, a functional magnetic resonance imaging (fMRI) paradigm, assesses striatal responses during reward anticipation.
Purpose of the Study:
- To investigate if fentanyl modulates striatal Blood Oxygenation Level Dependent (BOLD) responses during the MID task.
- To explore opioidergic modulation of striatal dopaminergic signaling.
Main Methods:
- 24 male participants underwent fMRI while performing the MID task after receiving intravenous fentanyl, naloxone, or placebo.
- End-tidal CO2 was monitored to control for respiratory effects.
Main Results:
- Fentanyl increased MID task BOLD responses during reward and loss anticipation compared to placebo and naloxone.
- These fentanyl-induced increases were observed in cortical regions (e.g., lingual gyrus, precuneus) rather than the striatum.
Conclusions:
- Fentanyl primarily affected BOLD responses in regions related to motor response preparation, not striatal reward processing areas.
- Opioid agonists may not directly influence striatal activation in tasks like the MID.
- Future research may benefit from using naturalistic rewards to study opioid effects on reward processing, and findings are limited to male participants.
Related Concept Videos
Opioid Receptors: Overview
420
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
420
Opioid Analgesics: Synthetic and Semisynthetic Opioids
203
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
203
Analgesia and Pain Management
420
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
420

